Franziska Michor, PhD

Publications

• Iwasa Y, Michor F.Evolutionary dynamics of intratumor heterogeneity.PLoS ONE. 2011;6(3):e17866.
  21479218
• Durrett R, Foo J, Leder K, Mayberry J, Michor F.Intratumor Heterogeneity in Evolutionary Models of Tumor Progression.Genetics. 2011 Mar 15.
  21406679
• Foo J, Leder K, Michor F.Stochastic dynamics of cancer initiation.Phys Biol. 2011 Feb;8(1):015002.
  21301064
• De Vargas Roditi L, Michor F.Evolutionary dynamics of BRCA1 alterations in breast tumorigenesis.J Theor Biol. 2011 Mar 21;273(1):207-15.
  21194536
• Leder K, Holland EC, Michor F.The therapeutic implications of plasticity of the cancer stem cell phenotype.PLoS ONE. 2010;5(12):e14366.
  21179426
• Michor F, Polyak K.The Origins and Implications of Intratumor Heterogeneity.Cancer Prev Res (Phila Pa). 2010 Nov;3(11):1361-4.
  20959519
• Attolini CS, Cheng YK, Beroukhim R, Getz G, Abdel-Wahab O, Levine RL, Mellinghoff IK, Michor F.A mathematical framework to determine the temporal sequence of somatic genetic events in cancer.Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17604-9.
  20864632
• Danielson LS, Menendez S, Attolini CS, Guijarro MV, Bisogna M, Wei J, Socci ND, Levine DA, Michor F, Hernando E.A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy.Am J Pathol. 2010 Aug;177(2)
  20558575
• Durrett R, Foo J, Leder K, Mayberry J, Michor F.Evolutionary dynamics of tumor progression with random fitness values.Theor Popul Biol. 2010 Aug;78(1):54-66.
  20488197
• Riester M, Stephan-Otto Attolini C, Downey RJ, Singer S, Michor F.A differentiation-based phylogeny of cancer subtypes.PLoS Comput. Biol. 2010 May;6(5):e1000777.
  20463876
• Foo J, Michor F.Evolution of resistance to anti-cancer therapy during general dosing schedules.J Theor Biol. 2010 Mar 21;263(2):179-88.
  20004211
• Haeno H, Michor F.The evolution of tumor metastases during clonal expansion.J Theor Biol. 2010 Mar 7;263(1):30-44.
  19917298
• Park SY, Gönen M, Kim HJ, Michor F, Polyak K.Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype.J Clin Invest. 2010 Feb 1;120(2):636-44.
  20101094
• Foo J, Michor F.Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.PLoS Comput. Biol. 2009 Nov;5(11):e1000557.
  19893626
• Haeno H, Levine RL, Gilliland DG, Michor F.A progenitor cell origin of myeloid malignancies.Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16616-21.
  19805346
• Michor F, Iwasa Y, Nowak MA.The age incidence of chronic myeloid leukemia can be explained by a one-mutation model.Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14931-4.
  17001000
• Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL, Nowak MA.Dynamics of chronic myeloid leukaemia.Nature. 2005 Jun 30;435(7046):1267-70.
  15988530